April 20, 2026
General Accident Insurance Co. Ja. Ltd.(GENAC)
Audited financials for the twelve months ended December 31, 2025:
General Accident Insurance Co. Ja. Ltd. (GENAC) reported a 14% year-over-year increase in insurance revenue for the twelve months ended December 31, 2025, totalling $13.07 billion, compared to $11.43 billion in the prior year.
Insurance service expenses amounted to $8.20 billion, reflecting a 20% increase over the $6.84 billion recorded in 2024. Net expenses from reinsurance contracts held were essentially flat, declining less than 1% to $4.32 billion, compared to $4.34 billion for the twelve-month period ended December 31, 2024.
The insurance service result improved 118% to $543.61 million, compared to $248.85 million in the prior year. Net investment income increased 36% to $560.50 million, up from $411.70 million in 2024. Finance expenses from insurance and reinsurance contracts amounted to $120.02 million (2024: $108.22 million). As a result, the net insurance and investment result for the twelve months amounted to $984.08 million, a 78% increase relative to the $552.33 million recorded in 2024.
Other operating income totalled $313.96 million, representing a 28% increase over the $244.43 million reported in 2024. Other operating expenses rose 38% to $685.02 million, up from $497.09 million in 2024.
Profit before taxation for the twelve months amounted to $613.02 million, a 105% increase over the $299.67 million reported in 2024.
The taxation charge increased 215% to $161.50 million, up from $51.34 million in the prior year. As a result, net profit for the twelve-month period amounted to $451.52 million, an 82% increase over $248.32 million reported in 2024.
Net profit attributable to shareholders for the year amounted to $441.95 million (2024: $241.33 million).
Unrealised gains on FVOCI investments declined 97% to $3.23 million, compared to $119.33 million reported in 2024. The foreign currency translation reserve decreased 78% to $15.49 million, from $69.42 million recorded in 2024. Total comprehensive income for the twelve months amounted to $470.23 million, compared to $437.08 million in the prior year, a 7.6% increase.
Consequently, Earnings Per Share for the twelve months amounted to $0.43 (2024: EPS: $0.23). The twelve-month trailing EPS was $0.43 and the number of shares used in these calculations was 1,031,250,000.
Notably, GENAC’s stock price closed the trading period on April 17, 2026, at a price of $6.35 with a corresponding P/E ratio of 14.82x.
Balance Sheet Highlights
The company’s total assets amounted to $23.38 billion, representing a significant increase of 91%, or $11.17 billion, compared to the $12.21 billion reported in the prior year.
This movement was primarily attributable to:
A $1.66 billion increase in cash and cash equivalents, rising to $3.81 billion (2024: $2.15 billion),
A substantial $8.01 billion increase in reinsurance contract assets, which climbed to $11.06 billion (2024: $3.05 billion),
A $1.15 billion increase in investment securities, moving to $4.38 billion (2024: $3.23 billion).
Shareholders’ equity was $4.29 billion (2024: $3.83 billion), representing a book value per share of $4.16 (2024: $3.72).
Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
